Our analysis identified asignificant increase in PTPN1 expression in colonadenocarcinoma (COAD) (log2FC = 0.76, p = 6.8 × 10–10), consistent with previously published analysis of TCGA or ClinicalProteomic Tumor Analysis Consortium (CPTAC) databases. Next, we conducted a pan-cancer survival analysisto evaluate the prognostic value of PTPN1 gene expressionacross 32 different cancer types (Figure B and Supplementary Figure S37). This evidence concerns the gene PTPN1 and cancer.